PARMAR KUSH — SEC insider filings

SEC reporting owner CIK 1664281. 64 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers the 50 most recent of 64 filings on record, filed 2021-06-25 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enliven Therapeutics, Inc. (ELVN)10% owner4—8 legs · 1,962,500 sh · $29,795,000—
CinCor Pharma, Inc. (CINC)10% owner34 legs · 1,070,000 sh · $25,520,000—8
Skye Bioscience, Inc. (SKYE)10% owner72 legs · 5,656,074 sh · $16,526,03125 legs · 1,055,553 sh · $2,995,503—
Rallybio Corp (RLYB)Director111 leg · 615,384 sh · $7,999,9927 legs · 560,000 sh · $6,735,50013
Camp4 Therapeutics Corp (CAMP)10% owner32 legs · 3,850,266 sh · $14,499,989—6
Artiva Biotherapeutics, Inc. (ARTV)10% owner11 leg · 833,333 sh · $9,999,996—5
Cabaletta Bio, Inc. (CABA)10% owner2—3 legs · 920,000 sh · $9,897,500—
Entrada Therapeutics, Inc. (TRDA)Director121 leg · 250,000 sh · $5,000,00014 legs · 623,729 sh · $4,715,15116
Vor Biopharma Inc. (VOR)Director, 10% owner2—2 legs · 330,706 sh · $5,059,8021
Latigo Biotherapeutics, Inc. (LTGO)10% owner1——6

+2 more issuers among the filings shown — every filing appears in the table below.

Insider filings — PARMAR KUSH

FiledFormIssuerReported transactionsSource
2026-09-244Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 27,612 @ $1.65 · Sale (S): 1,088 @ $1.65 · Sale (S): 114,851 @ $1.61 · Sale (S): 4,528 @ $1.61EDGAR
2026-09-184Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 32,607 @ $1.91 · Sale (S): 1,285 @ $1.91EDGAR
2026-08-204Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 45,090 @ $0.38 · Sale (S): 1,830 @ $0.38 · Sale (S): 253,080 @ $0.38 · Sale (S): 10,255 @ $0.35 · Sale (S): 409 @ $0.35 · Sale (S): 57,476 @ $0.35 · +3 moreEDGAR
2026-08-124Latigo Biotherapeutics, Inc. (LTGO)
jointly with 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., 5AM Opportunities II (GP), LLC, Schwab Andrew J.
Conversion (C): 4,975,543 · Conversion (C): 2,350,419 · Conversion (C): 3,152,305 (derivative) @ $0 · Conversion (C): 1,823,238 (derivative) @ $0 · Conversion (C): 866,018 (derivative) @ $0 · Conversion (C): 1,484,401 (derivative) @ $0EDGAR
2026-08-104Entrada Therapeutics, Inc. (TRDA)Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85 · Sale (S): 92,444 @ $7EDGAR
2026-08-054Camp4 Therapeutics Corp (CAMP)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., 5AM Partners VII, LLC, 5AM Ventures VII, L.P.
Purchase (P): 3,179,558 (derivative) @ $1.53EDGAR
2026-08-034Entrada Therapeutics, Inc. (TRDA)Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85EDGAR
2026-06-124Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2025-11-184Entrada Therapeutics, Inc. (TRDA)Sale (S): 200,000 @ $8.80EDGAR
2025-09-154Camp4 Therapeutics Corp (CAMP)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., 5AM Partners VII, LLC, 5AM Ventures VII, L.P.
Purchase (P): 2,941,176 @ $1.53EDGAR
2025-08-224Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 58,642 @ $3.57 · Sale (S): 2,314 @ $3.57 · Sale (S): 163,979 @ $3.42 · Sale (S): 6,470 @ $3.42EDGAR
2025-07-114Entrada Therapeutics, Inc. (TRDA)Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50EDGAR
2025-07-014Entrada Therapeutics, Inc. (TRDA)Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12EDGAR
2025-06-124Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-10-154Camp4 Therapeutics Corp (CAMP)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P.
Conversion (C): 1,716,055 · Conversion (C): 302,770 · Purchase (P): 909,090 @ $11 · Conversion (C): 15,002,166 (derivative) · Conversion (C): 4,244,770 (derivative) · Conversion (C): 3,395,816 (derivative)EDGAR
2024-09-134Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 214,556 @ $6.60 · Sale (S): 36,504 @ $6.60 · Sale (S): 1,440 @ $6.60 · Sale (S): 11,758 @ $6.06 · Sale (S): 2,000 @ $6.06 · Sale (S): 79 @ $6.06EDGAR
2024-07-244Artiva Biotherapeutics, Inc. (ARTV)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., Schwab Andrew J.
Conversion (C): 1,058,284 · Other (J): 112,966 @ $10.20 · Other (J): 348,721 @ $10.20 · Purchase (P): 833,333 @ $12 · Conversion (C): 843,592 (derivative) · Conversion (C): 214,692 (derivative)EDGAR
2024-06-144Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2024-05-174Rallybio Corp (RLYB)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2024-03-154Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, ROCKLAGE SCOTT M
Purchase (P): 450,000 @ $10EDGAR
2024-02-164Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., Schwab Andrew J.
Sale (S): 688,358 @ $14.90 · Sale (S): 136,642 @ $14.90EDGAR
2024-02-024Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, ROCKLAGE SCOTT M
Purchase (P): 5,206,074 @ $2.31EDGAR
2024-02-024Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., Schwab Andrew J.
Sale (S): 417,187 @ $15 · Sale (S): 82,813 @ $15EDGAR
2024-01-044Rallybio Corp (RLYB)Grant/award (A): 27,118 (derivative) @ $1.77EDGAR
2023-09-284Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., Schwab Andrew J.
Sale (S): 164,789 @ $15 · Sale (S): 32,711 @ $15EDGAR
2023-08-284Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., Schwab Andrew J.
Sale (S): 367,124 @ $16 · Sale (S): 72,876 @ $16EDGAR
2023-06-124Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2023-05-194Rallybio Corp (RLYB)Grant/award (A): 15,490 (derivative) @ $0EDGAR
2023-03-094Rallybio Corp (RLYB)Sale (S): 100,000 @ $8.20EDGAR
2023-02-284CinCor Pharma, Inc. (CINC)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., 5AM Opportunities I (GP), LLC
Code (U): 3,953,990 · Code (U): 487,333 · Code (U): 496,323EDGAR
2023-01-054Rallybio Corp (RLYB)Grant/award (A): 10,344 (derivative) @ $0EDGAR
2022-12-024Akouos, Inc. (AKUS)Code (U): 3,153,333 · Code (U): 982,453 · Disposition to issuer (D): 16,000 (derivative)EDGAR
2022-08-174CinCor Pharma, Inc. (CINC)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P.
Purchase (P): 112,667 @ $30 · Purchase (P): 487,333 @ $30EDGAR
2022-06-274Akouos, Inc. (AKUS)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2022-06-174Homology Medicines, Inc. (FIXX)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2022-06-164Vor Biopharma Inc. (VOR)Grant/award (A): 16,911 (derivative) @ $0EDGAR
2022-06-074Rallybio Corp (RLYB)Sale (S): 99,671 @ $12.50 · Sale (S): 50,329 @ $12.50EDGAR
2022-06-064Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 11,918 (derivative) @ $0EDGAR
2022-05-264Rallybio Corp (RLYB)Grant/award (A): 13,440 (derivative) @ $0EDGAR
2022-05-254Rallybio Corp (RLYB)Sale (S): 66,447 @ $13 · Sale (S): 33,553 @ $13EDGAR
2022-02-104Rallybio Corp (RLYB)Sale (S): 139,539 @ $13.05 · Sale (S): 70,461 @ $13.05EDGAR
2022-01-134CinCor Pharma, Inc. (CINC)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., Schwab Andrew J.
Conversion (C): 3,683,823 · Conversion (C): 183,823 · Purchase (P): 157,500 @ $16 · Purchase (P): 312,500 @ $16 · Conversion (C): 9,999,999 (derivative) @ $0 · Conversion (C): 2,525,000 (derivative) @ $0 · +1 moreEDGAR
2022-01-054Rallybio Corp (RLYB)Grant/award (A): 5,772 (derivative) @ $0EDGAR
2021-11-184Vor Biopharma Inc. (VOR)Sale (S): 238,870 @ $15.30 · Sale (S): 91,836 @ $15.30EDGAR
2021-11-054Entrada Therapeutics, Inc. (TRDA)Conversion (C): 318,616 · Conversion (C): 2,371,739 · Conversion (C): 564,217 · Conversion (C): 254,512 · Conversion (C): 318,140 · Purchase (P): 250,000 @ $20 · +5 moreEDGAR
2021-11-034Cabaletta Bio, Inc. (CABA)
jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, ROCKLAGE SCOTT M, Schwab Andrew J.
Sale (S): 258,456 @ $13 · Sale (S): 36,544 @ $13EDGAR
2021-11-014Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 23,552 (derivative) @ $0EDGAR
2021-09-094Cabaletta Bio, Inc. (CABA)
jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, ROCKLAGE SCOTT M, Schwab Andrew J.
Sale (S): 625,000 @ $9.70EDGAR
2021-08-044Rallybio Corp (RLYB)Other (J): 2,784,626 · Other (J): 790,714 · Purchase (P): 615,384 @ $13 · Other (J): 1,795,946 (derivative) · Other (J): 8,742,654 (derivative) · Other (J): 7,192,795 (derivative) · +2 moreEDGAR
2021-06-254Akouos, Inc. (AKUS)Grant/award (A): 16,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1664281 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs